Australia vaccine funding, Sinopharm’s global push, ECB accelerates stimulus
FT News Briefing
00:00
Navigating Vaccine Transparency and Gig Worker Rights
This chapter explores Sinopharm's struggle for international credibility amidst concerns over vaccine trial transparency, while positioning its vaccines as instruments of China's soft power in developing countries. It also examines Spain's landmark decision to reclassify gig workers as employees, granting them vital rights and signaling a shift in EU labor regulations.
Play episode from 02:13
Transcript
